173 related articles for article (PubMed ID: 11784154)
1. Carbonic anhydrase activators: design of high affinity isozymes I, II, and IV activators, incorporating tri-/tetrasubstituted-pyridinium-azole moieties.
Ilies M; Banciu MD; Ilies MA; Scozzafava A; Caproiu MT; Supuran CT
J Med Chem; 2002 Jan; 45(2):504-10. PubMed ID: 11784154
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase activators: high affinity isozymes I, II, and IV activators, incorporating a beta-alanyl-histidine scaffold.
Scozzafava A; Supuran CT
J Med Chem; 2002 Jan; 45(2):284-91. PubMed ID: 11784133
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase activators: synthesis of high affinity isozymes I, II and IV activators, derivatives of 4-(arylsulfonylureido-amino acyl)ethyl-1H-imidazole.
Supuran CT; Scozzafava A
J Enzyme Inhib; 2000; 15(5):471-86. PubMed ID: 11030087
[TBL] [Abstract][Full Text] [Related]
4. Pyridinium derivatives of histamine are potent activators of cytosolic carbonic anhydrase isoforms I, II and VII.
Dave K; Scozzafava A; Vullo D; Supuran CT; Ilies MA
Org Biomol Chem; 2011 Apr; 9(8):2790-800. PubMed ID: 21369613
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase activators: synthesis of high affinity isozymes I, II and IV activators, derivatives of 4-(4-tosylureido-amino acyl)ethyl-1H-imidazole (histamine derivatives).
Scozzafava A; Iorga B; Supuran CT
J Enzyme Inhib; 2000; 15(2):139-61. PubMed ID: 10938540
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase activators. Part 24. High affinity isozymes I, II and IV activators, derivatives of 4-(4-chlorophenylsulfonylureido-amino acyl)ethyl-1H-imidazole.
Scozzafava A; Supuran CT
Eur J Pharm Sci; 2000 Mar; 10(1):29-41. PubMed ID: 10699381
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating 2,4,6-trisubstituted-pyridinium-ethylcarboxamido moieties possessing membrane-impermeability and in vivo selectivity for the membrane-bound (CA IV) versus the cytosolic (CA I and CA II) isozymes.
Supuran CT; Scozzafava A; Ilies MA; Briganti F
J Enzyme Inhib; 2000; 15(4):381-401. PubMed ID: 10995069
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase activators - part 21. Novel activators of isozymes I, II and IV incorporating carboxamido and ureido histamine moieties.
Scozzafava A; Supuran CT
Eur J Med Chem; 2000 Jan; 35(1):31-9. PubMed ID: 10733601
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of histamine Schiff bases as carbonic anhydrase I, II, IV, VII, and IX activators.
Akocak S; Lolak N; Vullo D; Durgun M; Supuran CT
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1305-1312. PubMed ID: 29072105
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes.
Scozzafava A; Briganti F; Ilies MA; Supuran CT
J Med Chem; 2000 Jan; 43(2):292-300. PubMed ID: 10649985
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
[TBL] [Abstract][Full Text] [Related]
12. Investigation of piperazines as human carbonic anhydrase I, II, IV and VII activators.
Angeli A; Chiaramonte N; Manetti D; Romanelli MN; Supuran CT
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):303-308. PubMed ID: 29280407
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase I, II, IV and IX inhibition with a series of 7-amino-3,4-dihydroquinolin-2(1H)-one derivatives.
Bozdag M; Bua S; Osman SM; AlOthman Z; Supuran CT
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):885-892. PubMed ID: 28644059
[TBL] [Abstract][Full Text] [Related]
14. (Hetero)aryl substituted thiazol-2,4-yl scaffold as human carbonic anhydrase I, II, VII and XIV activators.
Rami M; Winum JY; Supuran CT; Melnyk P; Yous S
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):224-229. PubMed ID: 30734616
[TBL] [Abstract][Full Text] [Related]
15. The synthesis of novel pyrazole-3,4-dicarboxamides bearing 5-amino-1,3,4-thiadiazole-2-sulfonamide moiety with effective inhibitory activity against the isoforms of human cytosolic carbonic anhydrase I and II.
Mert S; Alım Z; İşgör MM; Beydemir Ş; Kasımoğulları R
Bioorg Chem; 2016 Oct; 68():64-71. PubMed ID: 27454619
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of human carbonic anhydrase isozymes I, II and VI with a series of bisphenol, methoxy and bromophenol compounds.
Balaydin HT; Durdaği S; Ekinci D; Sentürk M; Göksu S; Menzek A
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):467-75. PubMed ID: 21815772
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols.
Almajan GL; Innocenti A; Puccetti L; Manole G; Barbuceanu S; Saramet I; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 May; 15(9):2347-52. PubMed ID: 15837323
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with N-hydroxysulfamides--a new zinc-binding function in the design of inhibitors.
Winum JY; Innocenti A; Nasr J; Montero JL; Scozzafava A; Vullo D; Supuran CT
Bioorg Med Chem Lett; 2005 May; 15(9):2353-8. PubMed ID: 15837324
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase activators: amino acyl/dipeptidyl histamine derivatives bind with high affinity to isozymes I, II and IV and act as efficient activators.
Supuran CT; Scozzafava A
Bioorg Med Chem; 1999 Dec; 7(12):2915-23. PubMed ID: 10658596
[TBL] [Abstract][Full Text] [Related]
20. Facile synthesis and characterization of novel pyrazole-sulfonamides and their inhibition effects on human carbonic anhydrase isoenzymes.
Balseven H; Mustafa İşgör M; Mert S; Alım Z; Beydemir S; Ok S; Kasımoğulları R
Bioorg Med Chem; 2013 Jan; 21(1):21-7. PubMed ID: 23218470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
